The UK Lung Cancer Screening trial (UKLS) aims to evaluate low dose computed tomography (LDCT) lung cancer population screening in the UK. In UKLS, a large population sample aged 50-75y is approached with a questionnaire to determine lung cancer risk. Those with an estimated risk of at least 5% of developing lung cancer in the next five years (using the Liverpool Lung project risk model) are invited to participate in the trial. Here we present demographic, risk and response rate data from the first 88,897 individuals approached.
The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Fiona 
Introduction
Lung cancer kills more people in the UK than any other cancer. It accounts for over 20% of all deaths from malignancy, and 6% of total deaths; there were over 41,000 lung cancer diagnoses in 2009, and nearly 35,000 lung cancer deaths in 2010 (1) . Although improving, the five-year survival rate from lung cancer (all stages) is less than 10% for men and women; amongst the lowest for all cancer types (1) . The estimated cost of lung cancer to the NHS is £9071 per patient per year (compared with £2,776 per patient per year for all cancer types) (2) , and the total cost of lung cancer to the UK economy is £2.4 billion; more than for any other cancer (2) . This reflects the relatively high incidence of lung cancer being compounded by poor survival and high mortality, as most patients present at a late stage when they are unsuitable for curative treatment. Thus survival should be improved by a reduction in smoking, and through initiatives to achieve earlier diagnosis.
Worldwide, a number of screening trials for early detection of lung cancer have been, or are being, conducted (3). These have used both chest x-ray and low dose computed tomography (LDCT) screening; the latter is the superior method (3). The USA National Lung Screening Trial (NLST) randomised over 53,000 people aged 55-74, with a 30 pack year smoking history who had smoked within 15 years, to LDCT or chest X-ray. NLST reported a 20.0% relative reduction in lung cancer mortality in the LDCT arm (4) (5) . In Europe, the Dutch-Belgian randomised lung cancer screening trial (NELSON) is currently underway (6) . Screening for lung cancer relies firstly upon defining a high risk population; in the UK, criteria for this have been determined through the Liverpool Lung Project (LLP) (7, 8) . The LLP risk prediction model incorporates age, sex, family history of lung cancer, smoking, personal history of other cancer and non-malignant respiratory disease, and occupational exposure (7, 8) . The LLP model is a robust algorithm that has been validated on two international case-control populations (Harvard and EULC) and one independent cohort (LLP 7500) (9).
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Author Manuscript Published OnlineFirst on January 17, 2014; DOI: 10.1158/1940-6207.CAPR- The United Kingdom Lung Cancer Screening Trial (UKLS), which has recently completed its pilot phase of recruitment, is a multicentre randomised controlled trial (RCT) of LDCT for the early detection of lung cancer in high-risk subjects (>5% risk over five years, according to the LLP model) aged 50-75 years. The UKLS trial has recruited 4061 high-risk subjects over two discrete time periods in its pilot phase. (The first of these recruitment drives, yielding 1452 high risk participants, is the focus of this report).
The UKLS trial follows the Wald Single-Screen Design (10) . Subjects are randomised to receive either one LDCT scan (thus minimising problems with long term compliance), versus standard care. The trial design incorporates a number of elements that are unique to the area of lung cancer RCTs.
Firstly, UKLS is a population-based study, which randomly approached people aged 50-75 years through local Primary Care Trust (PCT) records. Secondly, UKLS employs the Liverpool Lung Project (LLP) lung cancer risk prediction model at an individual level (9) to identify high risk subjects; thus targeting resources to those most likely to benefit from screening. Thirdly, UKLS is unique in having a formal care pathway plan, based on categorisation (size, volume and growth) of lung nodules (10) Fourthly, UKLS uses state of the art volumetric analysis of lung nodules identified on LDCT scan: this has only been used consistently by one other trial (the Dutch-Belgian NELSON trial; (11)).
This report details the demographic characteristics of the target population in the UKLS pilot study, with the aim of identifying the factors associated with response or non-response to the study invitation. It is based on the initial round of approaches to 88,897 individuals, and the ensuing recruitment and randomisation of the first 1452 high risk participants for screening. It does not report CT data and outcomes as these data are not yet available. The implications of the findings for the implementation of population screening are discussed.
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Materials and Methods
The methods for the UKLS pilot study were derived from an initial feasibility study, and follow the Wald Single Screen Design (10) . Other Screening trials have used this design, including the UK Flexisig Trial, the UK Aortic Aneurysm Screening Trial and the Singapore Breast Screening Trial (12) (13) (14) . UKLS is similar in methodology to NELSON, and this will allow a combined analysis of results to increase the statistical power of both trials. Two main components were used in UKLS: an initial questionnaire-based screen to identify high risk individuals from the population, followed by an RCT with intervention (LDCT) and control arms. Supplementary Figure 1 illustrates the trial recruitment process. The necessary approvals were obtained from the National Research Ethics Service (NRES) and the National Information Governance Board (NIGB). An initial cohort of 88,897 individuals was approached, and it is this cohort that is described here.
Population Approaches
As UKLS is a population study, its starting point was NHS Primary Care Trust (PCT) records covering all UK citizens. From these records, individuals aged 50-75 years of age residing in three Primary Care Trust (PCT) areas around Liverpool, and three PCTs around Cambridgeshire, were randomly selected at the PCT. These data were provided to a third party data management company (DMC), who approached 88,897 individuals by post between August 2011 and March 2012 with an invitation letter (on the respective PCT-headed notepaper) and Questionnaire 1. This questionnaire covered smoking history and duration, personal history of non-malignant lung diseases (e.g. pneumonia) and previous malignancy, exposure to asbestos, and family history of lung and other cancers; in addition, it enquired whether the individual would be interested in participating in a screening study. For those who were unwilling to fill in the entire questionnaire, and who were not interested in participating further, there was a shorter non-participation questionnaire (covering smoking status, lung cancer prior experience and concern, and educational level), which they were asked to return instead. Approached subjects were categorised as follows, based on their response to the first Individuals who did not respond to the first invitation.
Risk Assessment
Completed Questionnaire 1s (from positive responders) were returned to the DMC, scanned, and the data analysed automatically in order to identify individuals at high risk (defined as >5%) of developing lung cancer over the next five years (LLP risk score ≥ 5) (8) . (Risk assessment was not carried out for negative responders, as this was not possible from the limited information they supplied). A modified version of the LLP risk algorithm (LLP v2 ) was utilised for risk calculations. This incorporated additional respiratory parameters (i.e. chronic obstructive pulmonary disease, emphysema, bronchitis and TB) as well as pneumonia, and also included both pipe and cigar usage within the smoking criteria. High risk individuals were contacted with a further questionnaire (Questionnaire 2) to establish eligibility for the RCT (10), and sent a detailed Patient Information Leaflet: these people were also asked to consent to release of their personal information to the UKLS research team. Non-responders to this second invitation were sent a reminder letter.
UKLS Research Clinics
Individuals responding to, and eligible on the basis of, the second questionnaire were invited to one of the recruitment centres (Liverpool Heart and Chest Hospital, or Papworth Hospital, Cambridge).
They were shown a DVD outlining the UKLS study (15) and consented by a Research Nurse. Subjects underwent spirometry, and provided blood, buccal swab, nasal, and sputum specimens. Recruits also completed a touch-screen questionnaire; this consisted of follow-up epidemiological and clinical questions, and psychosocial and quality of life questions including the Hospital Anxiety and Depression Scale (HADS) (16) and the Cancer Worry Scale (CWS-R) (17, 18) All smokers (both CT screened and non-screened) were offered smoking cessation advice sheets and a list of local NHS Stop Smoking services.
Recruits were randomised into the intervention arm (LDCT scan, screen group) or the control arm (usual care, no screen group) in a ratio of 1:1. Individuals were informed of which group they were in within two weeks of randomisation. Subjects in the intervention group received a thoracic LDCT scan several weeks later.
Follow up
Any lesions identified on LDCT-screening were treated as per the planned care pathway in the study protocol (10) (e.g. follow up scan or referral to multidisciplinary team). Health and mortality outcomes of UKLS participants in both study arms will be followed up for ten years, via the Office for National Statistics (ONS), the Hospital Episode Statistics (HES) database, and the National Cancer Registration Service. The full protocol for the UKLS study is available online (19).
Data storage and analysis
Data were input to and stored on a bespoke system builder database, built by Artex (Netherlands), with data security approved by the National Information Governance Board for Health and Social Care (NIGB). Statistical analysis was undertaken using STATA v12. 
Socioeconomic data analysis

Factors influencing response rate and risk
Sex
Men and women were approached in approximately equal numbers (n=44,618 and 44,279 respectively), and were equally likely to respond positively to the first questionnaire (26.7% of males and 26.9% of females were positive responders). However, men were 2.4 times as likely to be classified as at high LLP risk: 2016 (17%) of male and 832 (7%) of female positive responders had a high LLP risk. The frequency of non-responders was similar in men and women (65% of males; 62% of females), and the same was true of negative responders (8.3% of males; 11.1% of females).
Age
Positive response rate generally increased with age, from 23.6% in the 50-55 age group to 31.5% in the 66-70 age group. However, it was lower in the eldest (71-75) age group, at 24.1% (Figure 2a Table 1 . Almost 95% of high risk clinic attendees were aged 61-75 years (compared with 53% of the 88,897 subjects originally approached).
Considering individual years of age between 55 and 65, there was a slight but steady increase in response rate in older age groups, from 23.4% at age 55, to 35.1% at age 65. The percentage of the positive responders at high LLP risk increased with age, from 1.1% at age 55, to 16.5% at age 65, with a progressive increase starting from age 58 (Figure 2b ).
Socioeconomic Status
The English Index of Multiple Deprivation (IMD) rank (20) was available on 88,896 individuals. IMD data showed that the social demographics of the two recruitment areas (Liverpool and Cambridgeshire) were markedly different. Almost 50% of the Liverpool area residents approached for UKLS fell into the most deprived quintile of the English population, compared with less than 10% in Cambridgeshire. However, as planned in the pilot study design, the total UKLS approached sample The proportion of individuals with a high LLP risk score decreased with higher socioeconomic status; ranging from 17.7% in the most deprived quintile to 8.0% in the least deprived quintile (p<0.001;
Chi-squared for trend) (Figure 3) . As the social gradient of response and the social gradient of LLP risk were offset by each other, the socio-demographic spectrum of the individuals attending clinic was in proportion to that of the original approached sample ( Table 2 ). People attending clinic therefore spanned all IMD quintiles in roughly equal numbers, including a representative proportion from more deprived postcodes ( Figure 3 ; Table 2 ). However, of the individuals invited for screening, the clinic attendance rate increased with higher socioeconomic status (Figure 3) .
Smoking
Of the 23,784 positive responders, 23,562 (99%) gave information about their smoking habits. 45.4%
were never-smokers, 14.2% current smokers, and 40.4% ex-smokers (Figure 4) . Of the 8628 negative responders, 8163 (95%) provided information about their smoking habits. 54.9% were neversmokers, 9.3% current smokers, and 35.8% ex-smokers (Figure 4) . National smoking data (from the Office for National Statistics) for the 50+ age group give an expected distribution of 49.5% neversmokers, 17.5% current smokers, and 33% ex-smokers (21) 
Unsurprisingly, smokers and ex-smokers were much more likely than never-smokers to have an LLP risk of >5%. Of the 23,562 positive responders, 1094 (32.7% of 3345) current smokers and 1750 (18.4% of 9520) ex-smokers were designated high risk. However, only four (0.04% of 10,697) neversmokers had a high LLP risk: none of these attended a recruitment clinic, and all were aged at least 73 years. In total, therefore, 22.1% of current and ex-smoking positive responders were high risk, and 11.3% attended clinic and were recruited into UKLS.
Interaction between smoking and socioeconomic status
As people in more deprived socioeconomic groups are more likely to smoke, it is important to control for any possible confounding effects. Data were therefore stratified by both IMD quintile and smoking status. For all IMD national quintiles, the proportion of ex-smokers among positive responders was around 40%. 26.5% of positive responders in the most deprived quintile were current smokers, compared with only 8.6% in the least deprived quintile (Supplementary Table 1 ).
Within all IMD quintiles, there were proportionally more smokers (both current and ex) among positive compared to negative responders, and proportionally more never smokers among negative responders (Supplementary Table 1 ,2).
Based on known smoking prevalence rates for each IMD quintile, and adjusting for the age distribution of the UKLS sample (22), it was possible to calculate the expected number of smokers in each IMD quintile for the 88,897 approached subjects (Supplementary Table 3 ). This allowed an estimation of smoking status for non-responders in each IMD quintile, and hence the percentage of current smokers, ex-smokers and never smokers who respond positively to the first screening invitation ( Figure 5 ). The response rate is generally considerably lower among current smokers compared to the overall response rate for the relevant quintile (i.e. there is a smaller proportion of smokers amongst responders than would be expected from quintile-matched population figures). However, in the most and least deprived quintiles it appears that the response rate among smokers is similar to the overall response rate for that quintile ( Figure 5 ). For ex-smokers and never-smokers, positive response rate increases with socioeconomic status across all IMD quintiles, whereas the positive response rate amongst current smokers only rises in the upper two quintiles of IMD. The group least likely to respond positively are never smokers in the most deprived IMD quintile (calculated as 16.6% positive response rate), followed by current smokers in the three most deprived quintiles (calculated as 17.3-18.3% positive response rate). The highest positive response rate is seen in the ex-smokers from the least deprived IMD quintile (calculated as 37.3% positive response rate).
In the highest and lowest IMD quintiles, the calculated hierarchy of response rate is (from the highest): ex-smokers>current smokers>never smokers, whereas for the three middle IMD quintiles, it is: ex-smokers>never smokers>current smokers ( Figure 5 ). 
Discussion
This report focuses on the first 88,897 individuals approached for the UKLS pilot study, which utilises the LLP v2 risk model. As clinical outcome data become available, further analysis and validation of this risk algorithm will take place, which may result in further refinement of the LLP model. However, early data suggest that LLP v2 is effective at delineating risk in the UKLS population. Other major models have also been developed for identifying individuals with a high risk of lung cancer: these include Bach (23), Spitz (24), Tammemagi (25) , and more recently that of Kovalchik (26) . It is of note that two of these models (25, 26) have been used to analyse the NLST data. Tammemagi 74 age group in the UK give a male : female ratio of 1.34:1 (1). It will be interesting to consider sexrelated outcomes in the UKLS participants in future follow up through ONS, cancer registry and HES.
Age
In general, response rate increased with age, although there was a fall off in the oldest age group (71-75 years), who conceivably are less concerned about their risk of lung cancer, or anticipate more practical difficulties with participating in the study. Nevertheless, as the oldest age group has the greatest percentage at high LLP risk (28% of 71-75y positive responders were high risk) this age group was well represented in terms of clinic attendance (482, or 33.2%, of clinic attendees were aged 71-75y).Thus, despite the sharp fall off in participation rate in the oldest age group, the clinic attendance rate among this group is in proportion to the number of lung cancers expected (around one third of lung cancers in the UKLS age range occur in individuals of 71-75 years (1)).
Only 76 (5.2%) clinic attendees were aged 60 or below, of whom only five (0.3%) were in the 50-55y age group. Thus the youngest (50-55y) age group yielded a clinic attendance of just 0.02% of the 26,532 originally invited to participate in UKLS. This has implications for cost-effectiveness, and, under the LLP model of risk prediction, suggests that it would not be prudent to include this age group in any future lung screening studies or programmes.
In order to determine more accurately when response rate and risk increase to a point where screening is viable from a detection and cost-effectiveness point of view, we analysed by individual year of age within the 55-65 year age groups. The results suggest a fairly sharp increase at 58 years of age in the percentage of positive responders at high LLP risk, from around 1% to 4.3%. This suggests that setting the lower cut-off point for eligibility at 58 years old would be a reasonable strategy for future studies. By considering data only from individuals aged between 58-75 years responders in this age group, 2819 (17.7%) are at high LLP risk. The overall clinic attendance rate from the entire sample of 58-75 year olds (n=56,055) is 2.8%.
Socioeconomic Group
There was a strong positive correlation between higher socioeconomic group (less deprived quintile of IMD) and positive response to the screening invitation. Similar trends have also been observed in other screening studies, and the lower uptake is considered to relate to barriers including fear and fatalistic beliefs about cancer (27, 28) and poorer self-rated health in people from lower socioeconomic groups (29) . Unlike with other cancers (e.g. breast cancer) there are marked sociodemographic differences in lung cancer risk, with individuals from lower socioeconomic groups being at greater risk of developing the disease: this largely relates to disparate tobacco use in different socioeconomic groups. It is therefore not ideal that those at highest risk are the least likely to take up the offer of screening. Our data suggest that this works at two levels: individuals at highest risk of lung cancer (i.e. from the lower socioeconomic groups) are less likely to respond to the initial screening invitation, and also less likely to attend clinic after having been identified as at high risk.
Consideration will have to be given to addressing this in any future screening programme.
Smoking Status
Analysis suggested that ex-smokers are the most responsive to a screening invitation. It could be argued that consciously deciding to stop smoking and being motivated to participate in screening are related decisions, perhaps made by individuals who are more health aware, or perceive greater risks from smoking. The response rate from current smokers was lower than would be expected based on age matched population figures, possibly suggesting that current smokers are less likely to want to consider their cancer risk, or feel more threatened by the prospect of lung cancer screening.
However, it was observed that, if smokers take the trouble to respond, they are more likely in percentage terms to be positive rather than negative responders. The converse is true for never 
smokers, who perhaps, correctly, view their own risk as low and hence are over-represented amongst negative responders.
Interaction between smoking and IMD
The likelihood of a positive response to a CT screening invitation is lower both in more deprived socioeconomic groups, and in current smokers. As smoking status and socioeconomic status are closely related, it is important to establish whether both independently affect response rate, or whether there is any confounding. Predicted population smoking figures stratified by IMD quintile and age-adjusted to the UKLS sample (22) were therefore compared with the smoking prevalence seen amongst UKLS positive responders in each IMD quintile. This suggests that, in general, socioeconomic deprivation and current smoking status both act independently to lower the positive response rate. However, in the highest and lowest IMD quintiles, the impact of smoking status on response rate is much less marked. In the highest IMD quintile (least deprived), the positive response rate among smokers is slightly higher than the overall positive response rate. In the case of the results from the lowest (most deprived) IMD quintile, this observation partially offsets the trend for high risk individuals being less likely to respond. Across all socioeconomic groups, ex-smokers are the most likely to respond positively. In a possible future UK National lung CT screening programme, strategies may therefore need to be devised to target both current smokers and individuals from lower socioeconomic groups.
Conclusion
The data from the first phase (88,897 approaches) of the UKLS pilot trial provide a unique insight into the likely population response to a lung cancer screening trial in the UK. This will enable specific recommendations to be made regarding the implementation of any future UK-wide lung LDCT screening programme, such as initiating screening at age 58. Such a programme would need to give Crime (9.3%), and Living Environment Deprivation (9.3%). For the purposes of measuring deprivation, England is divided into 32,482 'Lower layer Super Output Areas' (LSOAs), with each area being carefully defined by its local geography, and containing in the region of 1500 residents (minimum 1000 residents). IMD ranks, which provide a relative measure of deprivation in small areas across England, range from 1 (most deprived LSOA) to 32,482 (least deprived LSOA). 
